Stock & Company Details
Fulcrum Therapeutics Inc $FULC
Price:
N/A
N/A
76M
$283M
52 Week High:
N/A
10 Day Average Volume:
N/A
-4.13
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
FULC technical indicators
Latest Fulcrum Therapeutics Inc (FULC) indicator readings as of 2026-11-19.
FULC's 14-day RSI is 49.0, in neutral territory. ADX reads 6.6, indicating a range-bound market rather than a trend. MACD (12, 26, 9) is 0.00, above the zero line.
Overview
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia. The company's proprietary product engine, FulcrumSeek, identifies drug targets that can modulate gene expression to treat the known root cause of gene mis-expression.
Finance Bot
Ask your questions
Start by typing a question below.